Bdc

All filings by Bdc on record concern Clementia Pharmaceuticals Inc. Between 14 August 2017 and 15 February 2019, the trades on record add up to 11 filings.

Sales make up the whole of the open-market record (10 sales, €1.5M). 2019 to date brings no purchases and 10 sales.

The newest entry dates from 18 February 2019: an open-market sale of €1.1M, in Clementia Pharmaceuticals Inc. Half of the filings or more reach the SEDI feed on the day of the trade. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.